BioLine RX Ltd (NASDAQ:BLRX)

2.72
Delayed Data
As of 3:59pm ET
 +0.04 / +1.49%
Today’s Change
2.32
Today|||52-Week Range
13.05
-58.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash5.5M2.5M5.1M3.4M
 
 
 
 
 
Short Term Investment Cash-245.9K-3.1M2.7M-1.7M
 
 
 
 
 
Cash & Short Term Investments47.7M35.6M49.5M30.2M
 
 
 
 
 
 
ReceivablesReceivables291.0K222.8K586.0K1.3M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses229.0K254.8K307.0K488.0K
 
 
 
 
 
Current Assets48.2M36.1M50.4M32.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.9M4.0M4.4M4.5M
 
 
 
 
 
Depreciation-954.0K-1.4M-1.8M-2.3M
 
 
 
 
 
Intangible Assets152.0K180.8K7.0M22.0M
 
 
 
 
 
Other Assets210.0K232.8K7.1M22.0M
 
 
 
 
 
Total Assets51.3M38.9M61.0M56.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.9M2.6M5.5M4.5M
 
 
 
 
 
Short Term Debt93.0K92.9K93.0K895.0K
 
 
 
 
 
Accrued Expenses705.0K559.5K620.0K792.0K
 
 
 
 
 
Other Current Liabilities715.0K574.5K639.0K806.0K
 
 
 
 
 
Other Liabilities3.1M3.7M6.7M6.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt344.0K249.8K157.0K7.8M
 
 
 
 
 
Other Liabilities208.0K999.061.2M323.0K
 
 
 
 
 
Total Liabilities3.7M3.9M8.1M14.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity47.6M35.0M52.9M41.3M
 
 
 
 
 
Total Shareholder Equity47.6M35.0M52.9M41.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding3.7M3.8M7.0M7.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.